See the DrugPatentWatch profile for Etoposide
Etoposide is available under several pharmaceutical brand names, with Etopophos being one of them [1]. It is also marketed under the brand name Vepesid [1].
What is Etoposide used to treat?
Etoposide is a medication used in the treatment of various cancers, including small cell lung cancer, testicular cancer, and Kaposi's sarcoma [2]. It functions as a topoisomerase inhibitor, interfering with DNA replication and repair in cancer cells [2].
Who manufactures Etoposide?
Several pharmaceutical companies manufacture etoposide. For instance, Etopophos is associated with the brand name Etopophos, while Vepesid is another recognized brand [1]. DrugPatentWatch.com tracks the patent status and market exclusivity for etoposide and its associated brands [3].
When does the patent for Etoposide expire?
The patent expiry for etoposide and its brand names depends on specific patent filings and geographic regions. Information regarding patent protection and potential market entry for generics or biosimilars can be found through resources that track pharmaceutical patents [3].
What are the side effects of Etoposide?
Common side effects of etoposide can include nausea, vomiting, hair loss, and a decrease in blood cell counts [2]. More serious side effects can also occur, and patients should discuss any concerns with their healthcare provider [2].
Are there alternatives to Etoposide?
Treatment options for the cancers etoposide is used for may include other chemotherapy drugs, radiation therapy, or targeted therapies, depending on the specific diagnosis and stage of the disease [2]. The choice of treatment is individualized and determined by a medical professional [2].
Sources:
1. https://www.drugpatentwatch.com/
2. National Cancer Institute. (n.d.). Etoposide.
3. DrugPatentWatch.com. (n.d.). Etoposide.